A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer
Clinical trial NCT03895788 · UNKNOWN
Trial details
- NCT number
- NCT03895788
- Sponsor
- Hunan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-14
- Primary completion
- 2019-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.